Literature DB >> 27605675

Cell-Cell Sensing of Viral Infection by Plasmacytoid Dendritic Cells.

Brian Webster1, Sonia Assil1, Marlène Dreux2.   

Abstract

All cells possess signaling pathways designed to trigger antiviral responses, notably characterized by type I interferon (IFN) production, upon recognition of invading viruses. Especially, host sensors recognize viral nucleic acids. Nonetheless, virtually all viruses have evolved potent strategies that preclude host responses within the infected cells. The plasmacytoid dendritic cell (pDC) is an immune cell type known as a robust type I IFN producer in response to viral infection. Evidence suggests that such functionality of the pDCs participates in viral clearance. Nonetheless, their contribution, which is likely complex and varies depending on the pathogen, is still enigmatic for many viruses. pDCs are not permissive to most viral infections, and consistently, recent examples suggest that pDCs respond to immunostimulatory viral RNA transferred via noninfectious and/or noncanonical viral/cellular carriers. Therefore, the pDC response likely bypasses innate signaling blockages induced by virus within infected cells. Importantly, the requirement for cell-cell contact is increasingly recognized as a hallmark of the pDC-mediated antiviral state, triggered by evolutionarily divergent RNA viruses.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27605675      PMCID: PMC5105643          DOI: 10.1128/JVI.01692-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Plasmacytoid dendritic cells control T-cell response to chronic viral infection.

Authors:  Luisa Cervantes-Barragan; Kanako L Lewis; Sonja Firner; Volker Thiel; Stephanie Hugues; Walter Reith; Burkhard Ludewig; Boris Reizis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

2.  Plasmacytoid dendritic cells reduce HIV production in elite controllers.

Authors:  K Machmach; M Leal; C Gras; P Viciana; M Genebat; E Franco; F Boufassa; O Lambotte; J P Herbeuval; E Ruiz-Mateos
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

Review 3.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

4.  Human pDCs preferentially sense enveloped hepatitis A virions.

Authors:  Zongdi Feng; You Li; Kevin L McKnight; Lucinda Hensley; Robert E Lanford; Christopher M Walker; Stanley M Lemon
Journal:  J Clin Invest       Date:  2014-11-21       Impact factor: 14.808

5.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

7.  Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity.

Authors:  Marlène Dreux; Urtzi Garaigorta; Bryan Boyd; Elodie Décembre; Josan Chung; Christina Whitten-Bauer; Stefan Wieland; Francis V Chisari
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

8.  A pathogenic picornavirus acquires an envelope by hijacking cellular membranes.

Authors:  Zongdi Feng; Lucinda Hensley; Kevin L McKnight; Fengyu Hu; Victoria Madden; Lifang Ping; Sook-Hyang Jeong; Christopher Walker; Robert E Lanford; Stanley M Lemon
Journal:  Nature       Date:  2013-03-31       Impact factor: 49.962

9.  Innate sensing of HIV-infected cells.

Authors:  Alice Lepelley; Stéphanie Louis; Marion Sourisseau; Helen K W Law; Julien Pothlichet; Clémentine Schilte; Laurence Chaperot; Joël Plumas; Richard E Randall; Mustapha Si-Tahar; Fabrizio Mammano; Matthew L Albert; Olivier Schwartz
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

Review 10.  The role of the cytoskeleton at the immunological synapse.

Authors:  Alex T Ritter; Karen L Angus; Gillian M Griffiths
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

View more
  21 in total

1.  Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.

Authors:  B Dominguez-Molina; K Machmach; C Perales; L Tarancon-Diez; I Gallego; J L Sheldon; M Leal; E Domingo; E Ruiz-Mateos
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 2.  Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.

Authors:  Rahnuma Ahmad; Mainul Haque
Journal:  Vaccines (Basel)       Date:  2022-04-14

Review 3.  Interferon-stimulated genes: new platforms and computational approaches.

Authors:  Richard Green; Reneé C Ireton; Michael Gale
Journal:  Mamm Genome       Date:  2018-07-07       Impact factor: 3.224

4.  Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs.

Authors:  Shixin Ma; Xiaoling Wan; Zihou Deng; Lei Shi; Congfang Hao; Zhenyuan Zhou; Chun Zhou; Yiyuan Fang; Jinghua Liu; Jing Yang; Xia Chen; Tiantian Li; Aiping Zang; Shigang Yin; Bin Li; Joel Plumas; Laurence Chaperot; Xiaoming Zhang; Guoliang Xu; Lubin Jiang; Nan Shen; Sidong Xiong; Xiaoming Gao; Yan Zhang; Hui Xiao
Journal:  J Exp Med       Date:  2017-04-17       Impact factor: 14.307

5.  Lethal Experimental Tick-Borne Encephalitis Infection: Influence of Two Strains with Similar Virulence on the Immune Response.

Authors:  Anastasia S Shevtsova; Oxana V Motuzova; Vera M Kuragina; Nelli K Akhmatova; Larissa V Gmyl; Yaroslava I Kondrat'eva; Liubov I Kozlovskaya; Yulia V Rogova; Alexander G Litov; Lidiya Iu Romanova; Galina G Karganova
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

6.  Immature particles and capsid-free viral RNA produced by Yellow fever virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferons.

Authors:  Laura Sinigaglia; Ségolène Gracias; Elodie Décembre; Matthieu Fritz; Daniela Bruni; Nikaïa Smith; Jean-Philippe Herbeuval; Annette Martin; Marlène Dreux; Frédéric Tangy; Nolwenn Jouvenet
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

7.  Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses.

Authors:  Brian Webster; Scott W Werneke; Biljana Zafirova; Sébastien This; Séverin Coléon; Elodie Décembre; Helena Paidassi; Isabelle Bouvier; Pierre-Emmanuel Joubert; Darragh Duffy; Thierry Walzer; Matthew L Albert; Marlène Dreux
Journal:  Elife       Date:  2018-06-19       Impact factor: 8.140

Review 8.  Interplay between SARS-CoV-2 and the type I interferon response.

Authors:  Margarida Sa Ribero; Nolwenn Jouvenet; Marlène Dreux; Sébastien Nisole
Journal:  PLoS Pathog       Date:  2020-07-29       Impact factor: 6.823

Review 9.  The signal pathways and treatment of cytokine storm in COVID-19.

Authors:  Lan Yang; Xueru Xie; Zikun Tu; Jinrong Fu; Damo Xu; Yufeng Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-07

10.  Immune-profiling of ZIKV-infected patients identifies a distinct function of plasmacytoid dendritic cells for immune cross-regulation.

Authors:  Xiaoming Sun; Stephane Hua; Ce Gao; Jane E Blackmer; Zhengyu Ouyang; Kevin Ard; Andrea Ciaranello; Sigal Yawetz; Paul E Sax; Eric S Rosenberg; Mathias Lichterfeld; Xu G Yu
Journal:  Nat Commun       Date:  2020-05-15       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.